- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/96 - Stabilising an enzyme by forming an adduct or a compositionForming enzyme conjugates
Patent holdings for IPC class C12N 9/96
Total number of patents in this class: 1685
10-year publication summary
|
156
|
160
|
151
|
124
|
142
|
99
|
77
|
73
|
57
|
49
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| aTyr Pharma, Inc. | 164 |
54 |
| President and Fellows of Harvard College | 6028 |
39 |
| Pangu BioPharma Limited | 106 |
38 |
| The Regents of the University of California | 20245 |
35 |
| Massachusetts Institute of Technology | 10124 |
32 |
| Novozymes A/S | 3333 |
30 |
| The Broad Institute, Inc. | 1868 |
28 |
| The General Hospital Corporation | 4793 |
22 |
| Regents of the University of Minnesota | 2725 |
20 |
| Life Technologies Corporation | 3340 |
18 |
| The Regents of the University of Colorado, a body corporate | 2711 |
17 |
| Toyota Motor Corporation | 33341 |
16 |
| Amicus Therapeutics, Inc. | 353 |
16 |
| Yale University | 2436 |
16 |
| Bioverativ Therapeutics Inc. | 214 |
15 |
| New England BioLabs, Inc. | 491 |
15 |
| BASF SE | 21083 |
14 |
| Board of Regents, The University of Texas System | 5921 |
14 |
| Comera Life Sciences, Inc. | 32 |
14 |
| BRANDEIS University | 334 |
13 |
| Other owners | 1219 |